Delivery Order SPE2DB22D2007-SPE2DB25FJ3KR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 24, 2025, with a ceiling value of $1,583.26 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery vehicle with DLA. This delivery order falls...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Naloxone HCl 4 mg nasal spray. The delivery order has a potential value of $2,039.75 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.63 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray (2-pack units) on July 23, 2025, with completion required by July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,671,806 units of 4 mg naloxone HCl nasal spray. The $1,958.16 contract has a completion date of February 16, 2024 and was awarded on February 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract with DLA valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,616.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4 mg naloxone hydrochloride nasal spray. The contract, which has an ultimate completion date of March 19, 2025, is not designated as a set-aside award. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- The Defense Logistics Agency awarded a $1,673.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 25, 2025, with completion targeted for July 28, 2025. This non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,781.16 to AmerisourceBergen Drug Corp for the delivery of Naloxone HCL 4 mg Nasal Spray. This order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corp, valued at $999,999,999.00, that provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract does not have a set-aside...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 4,563,955,933 units of Naloxone HCl 4 mg Nasal Spray in 2-count packages, with a total ceiling value of $5,637.45 and an ultimate completion date of March 14, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-pack units) on July 28, 2025, with completion scheduled for July 29, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $3,712.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3KRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,222.79. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 30, 2025, supporting federal medical procurement needs. The contract is classified as a child order under a larger indefinite delivery contract vehicle and carries no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The Naloxone HCL supply supports DLA's critical medical commodity needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/29/25 |